Shareholding disclosure

RTW Investments, LLC

Declared position

3.06%

Threshold

Crossed upwards

Timeline

Published

14.08.2014

Transaction

06.08.2014

Voting rights breakdown

Voting rights acquired3.06%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAE8D00013

Beneficial owner

RTW Investments, LLC

Declared address

RTW Investments, LLC, New York, NY 10019

Investment Manager

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

RTW Investments, LLC

Santhera Pharmaceuticals Holding AG14.08.2014TAE8D00013

Disclosure summary

RTW Investments, LLC disclosed a holding in Santhera Pharmaceuticals Holding AG on the acquisition side, published by SIX Exchange Regulation on 14.08.2014, at 3.06% of voting rights. Notice category: Single shareholder.

Disclosed position

3.06%

Voting rights acquired

Voting rights acquired3.06%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

RTW Investments, LLC disclosed a holding in Santhera Pharmaceuticals Holding AG, published on 14.08.2014.

Publication date14.08.2014

Transaction date06.08.2014

Issuing companySanthera Pharmaceuticals Holding AG

Beneficial ownerRTW Investments, LLC

Declared addressRTW Investments, LLC, New York, NY 10019

CategorySingle shareholder

Voting rights acquired3.06%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAE8D00013

Conditions

Investment Manager

Source: SIX Exchange Regulation · Publication date: 14.08.2014

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open